Haemonetics Corp. buy Mizuho
Start price
17.12.25
/
50%
€67.50
Target price
17.12.26
€76.62
Performance (%)
7.41%
Price
28.07.26
€73.00
Summary
This prediction is currently active. The BUY prediction by Mizuho shows slight gains of 7.41%. This prediction currently runs until 17.12.26. The prediction end date can be changed by Mizuho at any time. Mizuho has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Haemonetics Corp. | 5.797% | 5.797% |
| iShares Core DAX® | 2,59 % | 2,69 % |
| iShares Nasdaq 100 | -0,91 % | -7,37 % |
| iShares Nikkei 225® | 0,15 % | -10,20 % |
| iShares S&P 500 | -0,37 % | -0,83 % |
Comments by Mizuho for this prediction
In the thread Haemonetics Corp. diskutieren
Haemonetics (NYSE:HAE) had its price target raised by analysts at Mizuho from $75.00 to $90.00. They now have an "outperform" rating on the stock.
Ratings data for HAE provided by MarketBeat
Stopped prediction by Mizuho for Haemonetics Corp.
Haemonetics Corp.
Start price
Target price
Perf. (%)
€50.00
13.04.26
13.04.26
€59.89
13.04.27
13.04.27
47.00%
28.07.26
28.07.26
Haemonetics Corp.
Start price
Target price
Perf. (%)
€48.40
06.02.26
06.02.26
€67.86
06.02.27
06.02.27
50.83%
28.07.26
28.07.26